Sit Investment Associates Inc. held its position in shares of Monsanto Company (NYSE:MON) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 3,000 shares of the basic materials company’s stock at the end of the second quarter. Sit Investment Associates Inc.’s holdings in Monsanto were worth $355,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also made changes to their positions in the company. BlackRock Inc. boosted its position in shares of Monsanto by 2,390.1% in the first quarter. BlackRock Inc. now owns 26,192,816 shares of the basic materials company’s stock worth $2,965,029,000 after buying an additional 25,140,936 shares during the period. State Street Corp increased its position in shares of Monsanto by 1.2% in the first quarter. State Street Corp now owns 20,153,966 shares of the basic materials company’s stock worth $2,281,433,000 after buying an additional 234,582 shares in the last quarter. Massachusetts Financial Services Co. MA increased its position in shares of Monsanto by 3.6% in the first quarter. Massachusetts Financial Services Co. MA now owns 14,299,502 shares of the basic materials company’s stock worth $1,618,703,000 after buying an additional 499,639 shares in the last quarter. Geode Capital Management LLC increased its position in shares of Monsanto by 7.7% in the first quarter. Geode Capital Management LLC now owns 4,125,879 shares of the basic materials company’s stock worth $466,359,000 after buying an additional 295,452 shares in the last quarter. Finally, Flossbach Von Storch AG increased its position in shares of Monsanto by 33.9% in the first quarter. Flossbach Von Storch AG now owns 4,089,400 shares of the basic materials company’s stock worth $462,920,000 after buying an additional 1,034,400 shares in the last quarter. Hedge funds and other institutional investors own 75.31% of the company’s stock.
Shares of Monsanto Company (MON) opened at 116.55 on Friday. The firm has a market cap of $51.20 billion, a P/E ratio of 25.17 and a beta of 1.07. Monsanto Company has a 52-week low of $97.35 and a 52-week high of $118.97. The company’s 50-day moving average is $117.47 and its 200-day moving average is $115.08.
Monsanto (NYSE:MON) last released its quarterly earnings data on Wednesday, June 28th. The basic materials company reported $1.93 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.74 by $0.19. Monsanto had a return on equity of 45.26% and a net margin of 14.11%. The company had revenue of $4.23 billion during the quarter, compared to analysts’ expectations of $4.18 billion. During the same period last year, the firm posted $2.17 earnings per share. The business’s revenue was up 1.0% on a year-over-year basis. Equities research analysts forecast that Monsanto Company will post $4.89 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Friday, October 6th will be paid a dividend of $0.54 per share. The ex-dividend date is Thursday, October 5th. This represents a $2.16 dividend on an annualized basis and a dividend yield of 1.85%. Monsanto’s dividend payout ratio (DPR) is currently 46.75%.
ILLEGAL ACTIVITY NOTICE: “Monsanto Company (NYSE:MON) Position Held by Sit Investment Associates Inc.” was originally reported by Community Financial News and is the sole property of of Community Financial News. If you are reading this story on another website, it was stolen and republished in violation of US and international trademark and copyright laws. The correct version of this story can be read at https://www.com-unik.info/2017/08/12/sit-investment-associates-inc-has-355000-stake-in-monsanto-company-nysemon-updated-updated.html.
A number of equities analysts have recently commented on the stock. Citigroup Inc. reaffirmed a “neutral” rating and issued a $125.00 target price (up from $122.00) on shares of Monsanto in a report on Friday, April 14th. BidaskClub raised shares of Monsanto from a “sell” rating to a “hold” rating in a report on Thursday, June 29th. Vetr raised shares of Monsanto from a “hold” rating to a “buy” rating and set a $122.35 target price on the stock in a report on Tuesday, June 27th. Barclays PLC boosted their price objective on shares of Monsanto from $115.00 to $120.00 and gave the company an “equal weight” rating in a research note on Thursday, June 29th. Finally, Jefferies Group LLC cut shares of Monsanto from a “buy” rating to a “hold” rating and set a $128.00 price objective on the stock. in a research note on Wednesday, July 12th. Two analysts have rated the stock with a sell rating, eleven have given a hold rating and eight have assigned a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus price target of $123.15.
In other Monsanto news, EVP Robert T. Fraley sold 52,410 shares of the firm’s stock in a transaction on Monday, July 10th. The stock was sold at an average price of $117.95, for a total transaction of $6,181,759.50. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, EVP Steven Mizell sold 11,300 shares of the firm’s stock in a transaction on Monday, July 3rd. The stock was sold at an average price of $118.57, for a total value of $1,339,841.00. Following the transaction, the executive vice president now owns 55,011 shares in the company, valued at approximately $6,522,654.27. The disclosure for this sale can be found here. In the last quarter, insiders have sold 74,470 shares of company stock worth $8,791,281. 0.79% of the stock is owned by corporate insiders.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
What are top analysts saying about Monsanto Company? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Monsanto Company and related companies.